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Abstract
Circadian rhythm sleep–wake disorders (CRSWDs) are characterized by disturbed sleep–wake patterns. We genotyped
a PER3 variable number tandem repeat (VNTR) in 248 CRSWD individuals and 925 controls and found no signiﬁcant
association between the VNTR and CRSWDs or morningness–eveningness (diurnal) preferences in the Japanese
population. Although the VNTR has been associated with circadian and sleep phenotypes in some other populations,
the polymorphism may not be a universal genetic marker.
Circadian clocks regulate daily behavioral and physio-
logical rhythms, such as sleep and wakefulness1. The
molecular mechanism of the circadian clock system
involves transcription–translation-negative feedback
loops of multiple clock genes, including ARNTL (also
known as BMAL1), Casein Kinase I (CKI), CLOCK, CRY,
and PER. The BMAL1 and CLOCK proteins form het-
erodimers and activate transcription of CRY and PER. The
CRY and PER proteins gradually accumulate in the
cytoplasm, and CRY, PER, and CKI proteins form com-
plexes that translocate to the nucleus. These protein
complexes interact with BMAL1–CLOCK heterodimers,
thereby inhibiting transcription of the CRY and
PER genes2. Circadian rhythm sleep–wake disorders
(CRSWDs) are deﬁned by persistent or recurrent dis-
turbed sleep–wake patterns and are thought to result
from impairment of the circadian clock system3. CRSWDs
consist of several subtypes, including delayed sleep–wake
phase disorder (DSWPD) and non-24-hour sleep–wake
rhythm disorder (N24SWD). DSWPD is characterized by
signiﬁcantly delayed sleep timing, while N24SWD is
characterized by sleep timing that progressively delays
each day in normal real-life settings. Additionally,
circadian and sleep characteristics vary greatly among
individuals4. A number of studies have shown that
genetic factors signiﬁcantly contribute to individual
differences in daily activity/sleep time, known as
morningness–eveningness preferences (or diurnal pre-
ferences), and sleep phenotypes5. The PER3 gene has a
variable number tandem repeat (VNTR) consisting of
either 4 or 5 repeated 54-bp sequences encoding 18 amino
acids6. The 4-repeat allele of the VNTR has been asso-
ciated with extreme evening preference and DSWPD6,7,
while the 5-repeat allele of the VNTR has been associated
with extreme morning preference and greater sleep pro-
pensity7,8. However, the frequency of the VNTR poly-
morphism differs among various populations9,10 and has
not been examined in a large Japanese cohort of CRSWD
patients and controls. In this study, we genotyped the
PER3 VNTR polymorphism in 180 individuals with
DSWPD, 68 individuals with N24SWD, and 925 controls
and tested the VNTR polymorphism for associations with
CRSWD phenotypes in the patient group and with diurnal
preferences in the control group.
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The study population consisted of 180 DSWPD indivi-
duals (109 men and 71 women; mean ± SD age: 26.71 ±
9.29 years), 68 N24SWD individuals (48 men and 20
women; mean ± SD age: 26.63 ± 9.74 years), and 925
controls (274 men and 651 women; mean ± SD age: 36.45
± 12.10 years). Patient subjects and controls had been
examined in an earlier study of ours11. All participants
were unrelated, sighted Japanese men and women who
were recruited at medical and research institutes in Japan.
None of the controls had a history of sleep disorders or
psychosis. The DSWPD and N24SWD patients were
diagnosed by trained psychiatrists according to the
International Classiﬁcation of Sleep Disorders, Third
Edition (ICSD-III, 2014)12. Diurnal preferences were
assessed by the Japanese version of the Horne–Östberg
Morningness-Eveningness Questionnaire (MEQ)13 in our
previous study11. The 925 controls consisted of 245
morning types (79 men and 166 women; mean ± SD age:
36.23 ± 12.19 years), 594 intermediate types (163 men and
431 women; mean ± SD age: 36.86 ± 12.05 years), and 86
evening types (32 men and 54 women; mean ± SD age:
37.60 ± 10.69 years). The protocol was approved by the
respective institutional ethical review boards. All subjects
provided written informed consent. The present study
was conducted according to the principles of the
Declaration of Helsinki.
The 4- or 5-repeat allele of the PER3 VNTR was
assessed by polymerase chain reaction (PCR). The primers
used to amplify the DNA fragments containing 4 or 5
repeated 54-bp sequences were as follows: 5′-CAAAATT
TTATGACACTACCAGAATGGCTGAC-3′, 5′-AACCT
TGTACTTCCACATCAGTGCCTGG-3′. The PCR reac-
tion was carried out in a 10-µl mixture containing
AmpliTaq Gold 360 Master Mix and 360 GC Enhancer
(Thermo Fisher Scientiﬁc, CA, USA), 1 µM of each pri-
mer, and 10 ng of genomic DNA and run in the GeneAmp
PCR System 9600 (Thermo Fisher Scientiﬁc, CA, USA).
Ampliﬁcation conditions were as follows: 1 cycle of 95 °C
for 5 min, 35 cycles of 95 °C for 30 s, 60 °C for 30 s, 72 °C
for 30 s, and 1 cycle of 72 °C for 7 min. The PCR frag-
ments were subject to electrophoresis in a 3% agarose gel.
Table 1 shows the genotypic and allelic distribution of
the PER3 VNTR in controls, DSWPD individuals, and
N24SWD individuals. Homozygosity for the 4-repeat
allele PER3-(4/4) is the most common (63.89–70.59 %),
and homozygosity for the 5-repeat allele PER3-(5/5) is the
least common (0–5 %), with the 4-repeat allele having
higher prevalence (79.44–85.29 %) than the 5-repeat allele
(14.71–20.56 %) in the control, DSWPD, and N24SWD
groups. The allele frequency of the PER3 VNTR was
compared among the three groups, and no signiﬁcant
difference was identiﬁed in the VNTR frequency (χ2=
3.0608, P= 0.2165). The PER3 VNTR was not associated
with CRSWD phenotypes in our study samples. We then
assessed the association of the PER3 VNTR with diurnal
preferences (Table 2). Similarly, PER3-(4/4) is the most
common polymorphism (62.79–70.88 %), PER3-(5/5) is
the least common polymorphism (1.63–5.81 %), and the
4-repeat allele is more prevalent (78.49–83.67 %) than the
5-repeat allele (16.33–21.51 %) in the morning-, inter-
mediate-, and evening-type groups. The VNTR alleles did
not differ among these three types (χ2= 3.1694, P=
Table 1 Genotype and allele frequency of the PER3 VNTR in the control, DSWPD and N24SWD groups
Group N Genotype [N (%)] Allele [N (%)] χ2 P
4/4 4/5 5/5 4 5
Control 925 635 (68.65) 260 (28.11) 30 (3.24) 1530 (82.70) 320 (17.30) 3.0608 0.2165
DSWPD 180 115 (63.89) 56 (31.11) 9 (5.00) 286 (79.44) 74 (20.56)
N24SWD 68 48 (70.59) 20 (29.41) 0 (0.00) 116 (85.29) 20 (14.71)
N number, 4/4 homozygosity for the 4-repeat allele, 4/5 heterozygosity, 5/5 homozygosity for the 5-repeat allele, P P value for the difference in allele frequency among
the control, DSWPD, and N24SWD groups
Table 2 Genotype and allele frequency of the PER3 VNTR in the morning, intermediate, and evening types
Type N Genotype [N (%)] Allele [N (%)] χ2 P
4/4 4/5 5/5 4 5
Morning 245 160 (65.31) 81 (33.06) 4 (1.63) 401 (81.84) 89 (18.16) 3.1694 0.205
Intermediate 594 421 (70.88) 152 (25.59) 21 (3.54) 994 (83.67) 194 (16.33)
Evening 86 54 (62.79) 27 (31.40) 5 (5.81) 135 (78.49) 37 (21.51)
N number, 4/4 homozygosity for the 4-repeat allele, 4/5 heterozygosity, 5/5 homozygosity for the 5-repeat allele, P P value for the difference in allele frequency among
the morning, intermediate, and evening types
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0.205). No signiﬁcant association was identiﬁed between
the PER3 VNTR and diurnal preferences in our control
samples. Age-adjusted MEQ scores were 52.93 ± 7.86
(mean ± SD) for PER3-(4/4), 53.56 ± 8.57 for PER3-(4/5),
and 50.02 ± 8.06 for PER3-(5/5). There was no difference
in age-adjusted MEQ scores among the three genotypes
(F(2, 922)= 2.171; P= 0.115).
We found no signiﬁcant association of the PER3 VNTR
with CRSWD phenotypes or diurnal preferences in our
Japanese cohort. The frequency distribution of the PER3
VNTR differs among African American, European
American, Ghana Africans, Han Chinese, and Italian
populations10,14. The data indicate that the associations
between the VNTR and circadian and sleep phenotypes
could differ among populations. Signiﬁcant associations
between the VNTR and diurnal preferences were found
in the British populations7,15 but not in the Han Chinese
populations14. The PER3 VNTR may not be an
appropriate genetic marker for predicting circadian and
sleep phenotypes in some populations, including the
Japanese population. However, a number of studies indi-
cate close links between the PER3 gene and circadian
rhythms and sleep homeostasis8,16,17. Polymorphisms in
the PER3 promoter are associated with DSWPD and these
polymorphisms alter PER3 expression levels18. Our pre-
vious study demonstrated that a missense polymorphism
in the PER3 coding region (rs228697) is associated with
N24SWD and diurnal preferences11. Additionally, another
group has recently identiﬁed the association of rs228697
with diurnal preferences19. Furthermore, the PER3 pro-
tein with the rs228697 variant has been shown to be a
strong repressor for CLOCK–BMAL1-induced tran-
scription20. These ﬁndings suggest that the PER3 gene
could play an important role in the circadian clock system
and sleep regulation.
In conclusion, our data show no signiﬁcant association
between the PER3 VNTR and CRSWD phenotypes or
diurnal preferences in our Japanese cohort. The results of
our study imply that the PER3 VNTR may not be a uni-
versal genetic marker for an individual’s circadian and
sleep phenotypes.
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